SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-027520
Filing Date
2021-05-18
Accepted
2021-05-18 12:57:08
Documents
12
Period of Report
2021-05-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea140989-8k_orionbiotech.htm 8-K 37549
2 UNDERWRITING AGREEMENT, DATED MAY 12, 2021, BETWEEN THE COMPANY AND CANTOR FITZG ea140989ex1-1_orionbio.htm EX-1.1 232194
3 AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION ea140989ex3-1_orionbio.htm EX-3.1 432168
4 WARRANT AGREEMENT, DATED MAY 12, 2021, BETWEEN CONTINENTAL STOCK TRANSFER & TRUS ea140989ex10-1_orionbio.htm EX-10.1 182639
5 PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, DATED MAY 12, 2021, BETWEEN THE C ea140989ex10-2_orionbio.htm EX-10.2 43974
6 INVESTMENT MANAGEMENT TRUST ACCOUNT AGREEMENT, DATED MAY 12, 2021, BETWEEN CONTI ea140989ex10-3_orionbio.htm EX-10.3 81045
7 REGISTRATION AND SHAREHOLDER RIGHTS AGREEMENT, DATED MAY 12, 2021, AMONG THE COM ea140989ex10-4_orionbio.htm EX-10.4 166162
8 LETTER AGREEMENT, DATED MAY 12, 2021, AMONG THE COMPANY, THE SPONSOR AND THE COM ea140989ex10-5_orionbio.htm EX-10.5 61370
9 ADMINISTRATIVE SERVICES AGREEMENT, DATED MAY 12, 2021, BETWEEN THE COMPANY AND T ea140989ex10-6_orionbio.htm EX-10.6 10388
10 FORWARD PURCHASE AGREEMENT, DATED MAY 12, 2021, BETWEEN THE COMPANY AND ORION SP ea140989ex10-7_orionbio.htm EX-10.7 119395
11 PRESS RELEASE, DATED MAY 12, 2021 ea140989ex99-1_orionbio.htm EX-99.1 8783
12 PRESS RELEASE, DATED MAY 17, 2021 ea140989ex99-2_orionbio.htm EX-99.2 10084
  Complete submission text file 0001213900-21-027520.txt   1387033
Mailing Address 645 FIFTH AVENUE, 21ST FLOOR NEW YORK NY 10022
Business Address 645 FIFTH AVENUE, 21ST FLOOR NEW YORK NY 10022 212-303-7822
Orion Biotech Opportunities Corp. (Filer) CIK: 0001847416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40410 | Film No.: 21935306
SIC: 6770 Blank Checks